X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indoco Remedies Fact Sheet, Indoco Remedies Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indoco Remedies Fact Sheet   (INDOCO)

Here is the latest financial fact sheet of Indoco Remedies. For more details, see the Indoco Remedies quarterly results and Indoco Remedies share price and chart. For a sector overview, read our pharmaceuticals sector report.

INDOCO REMEDIES Price History

Price Rs 158.1
Mkt Cap Rs m 14,573
Vol '000 0.7
P/E X -513.1
P/CF X 13.4
EPS (TTM) Rs -0.3
% ch % -0.9
No. of shares m 92.18
% ch week % -8.5
% ch 1-mth % -12.9
% ch 12-mth % -19.6
52 week H/L Rs 238.0/150.3
(As on Jun 14, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

INDOCO REMEDIES Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
INDOCO REMEDIES EQUITY SHARE DATA
High Rs162378412360317 
Low Rs55131263249178 
Sales per share (Unadj.) Rs79.593.0109.4116.6113.1 
Earnings per share (Unadj.) Rs6.39.08.98.44.5 
Diluted earnings per shareRs6.39.08.98.44.5 
Cash flow per share (Unadj.) Rs9.614.115.515.211.8 
Dividends per share (Unadj.) Rs1.401.601.601.601.00 
Adj. dividends per shareRs1.401.601.601.601.00 
Dividend yield (eoy) %1.30.60.50.50.4 
Book value per share (Unadj.) Rs49.657.362.670.773.2 
Adj. book value per shareRs49.657.362.570.773.2 
Shares outstanding (eoy) m92.1592.1592.1592.1592.15 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x1.42.73.12.62.2 
Avg P/E ratio x17.228.337.936.455.5 
P/CF ratio (eoy) x11.218.021.820.021.0 
Price / Book Value ratio x2.24.45.44.33.4 
Dividend payout %22.217.818.019.122.4 
Avg Mkt Cap Rs m9,98923,43831,08728,08322,830 
No. of employees `000NANA5.76.05.5 
Total wages/salary Rs m1,2951,4001,8192,1672,209 
Avg. sales/employee Rs ThNMNM1,762.41,780.61,910.1 
Avg. wages/employee Rs ThNMNM318.0359.0405.0 
Avg. net profit/employee Rs ThNMNM143.3127.775.5 
INDOCO REMEDIES INCOME DATA
Net Sales Rs m7,3268,57010,08110,74810,419 
Other income Rs m1817164047 
Total revenues Rs m7,3448,58710,09710,78710,466 
Gross profit Rs m1,2041,6551,7041,5651,349 
Depreciation Rs m309471607633677 
Interest Rs m18910612462235 
Profit before tax Rs m7231,096989909484 
Minority Interest Rs m-10000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m14326717013972 
Profit after tax Rs m580828819771412 
Gross profit margin %16.419.316.914.612.9 
Effective tax rate %19.824.417.215.315.0 
Net profit margin %7.99.78.17.24.0 
INDOCO REMEDIES BALANCE SHEET DATA
Current assets Rs m3,0463,8904,6465,7215,373 
Current liabilities Rs m2,0222,9263,6413,9044,157 
Net working cap to sales %14.011.310.016.911.7 
Current ratio x1.51.31.31.51.3 
Inventory Days Days5564606368 
Debtors Days Days6966687373 
Net fixed assets Rs m3,6944,0224,2965,3076,244 
Share capital Rs m184184184184184 
"Free" reserves Rs m4,3805,0935,5816,3296,566 
Net worth Rs m4,5725,2775,7656,5136,750 
Long term debt Rs m1381293791,3231,233 
Total assets Rs m7,2948,2039,40611,96812,363 
Interest coverage x4.811.49.015.63.1 
Debt to equity ratio x000.10.20.2 
Sales to assets ratio x1.01.01.10.90.8 
Return on assets %10.511.410.07.05.2 
Return on equity %12.715.714.211.86.1 
Return on capital %19.422.218.112.49.0 
Exports to sales %33.936.240.100 
Imports to sales %5.47.57.700 
Exports (fob) Rs m2,4803,1014,04400 
Imports (cif) Rs m39664377300 
Fx inflow Rs m2,4803,1014,0444,5073,762 
Fx outflow Rs m5498191,0171,1411,143 
Net fx Rs m1,9312,2823,0273,3662,619 
INDOCO REMEDIES CASH FLOW
From Operations Rs m 988 1,090 1,122 886 1,227 
From Investments Rs m -410 -884 -1,107 -1,706 -1,360 
From Financial Activity Rs m -590 -199 -16 1,316 -388 
Net Cashflow Rs m -12 7 -1 497 -521 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 59.2%
Foreign collaborators 0.0%
Indian inst/Mut Fund 12.5%
FIIs 6.0%
ADR/GDR 0.0%
Free float 22.4%
Shareholders 12,805
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 166, Indoco House, CST Road, kalina, Santacruz (E), Mumbai - 400 098
E-MAIL sunil.joshi@indoco.com WEB www.indoco.com
TELEPHONE (022) 2654 1851 FAX (022) 2652 3067
SECTOR MISCELLANEOUS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
AUDITOR Patkar & Pendse
CHM: Suresh G. Kare (MD) COMP SEC: Sunil D. Joshi YEAR OF INC: 1945 BSE CODE: 532612 FV (Rs): 2 DIV YIELD (%): 0.6

Read: INDOCO REMEDIES 2017-18 Annual Report Analysis

More Miscellaneous Company Fact Sheets:   INDRAPRASTHA MEDICAL  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  NATCO PHARMA  PANACEA BIOTECH  

Compare INDOCO REMEDIES With:   INDRAPRASTHA MEDICAL  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  NATCO PHARMA  PANACEA BIOTECH  

Compare INDOCO REMEDIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Jet Airways and Yes Bank - What's Next for these Beaten Down Stocks?(Podcast)

Jet Airways and Yes Bank, both once market darlings are now being shunned by market participants. The National Stock Exchange (NSE) exchange notified that the shares of the airline.

Views on news

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Best 4 Small-cap Stocks to Buy(The 5 Minute Wrapup)

Jun 3, 2019

In the sometimes good sometimes bad market of small caps, there are strong buying opportunities available today. But this great opportunity won't last forever.

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Top 7 Stocks to Profit from Modi's Repeat Performance(Profit Hunter)

Jun 3, 2019

The long-term India story looks promising with the Modi government back in power. Which stocks are likely to go up the most?

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 8-QTR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS